Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

R Chowdhury, H Khan, E Heydon… - European heart …, 2013 - academic.oup.com
Aims The aim of this study was to determine the extent to which adherence to individual
vascular medications, assessed by different methods, influences the absolute and relative …

Gender differences in the effects of cardiovascular drugs

J Tamargo, G Rosano, T Walther… - European Heart …, 2017 - academic.oup.com
An initiation-promotion protocol was used to test the hypothesis that unleaded gasoline (UG)
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial

JS Kutner, PJ Blatchford, DH Taylor… - JAMA internal …, 2015 - jamanetwork.com
Importance For patients with limited prognosis, some medication risks may outweigh the
benefits, particularly when benefits take years to accrue; statins are one example. Data are …

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of …

PS Jellinger, Y Handelsman, PD Rosenblit… - Endocrine Practice, 2017 - Elsevier
Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

Statins for the primary prevention of cardiovascular disease

F Taylor, K Ward, THM Moore, M Burke… - Cochrane database …, 2011 - cochranelibrary.com
Background Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD)
events in people with and without a past history of coronary heart disease (CHD) is an …

Inflammaging as a target for healthy ageing

B Dugan, J Conway, NA Duggal - Age and Ageing, 2023 - academic.oup.com
Life expectancy has been on the rise for the past few decades, but healthy life expectancy
has not kept pace, leading to a global burden of age-associated disorders. Advancing age is …

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

G Guyatt, AD Oxman, S Sultan, J Brozek… - Journal of clinical …, 2013 - Elsevier
GRADE requires guideline developers to make an overall rating of confidence in estimates
of effect (quality of evidence—high, moderate, low, or very low) for each important or critical …

How to use a subgroup analysis: users' guide to the medical literature

X Sun, JPA Ioannidis, T Agoritsas, AC Alba, G Guyatt - Jama, 2014 - jamanetwork.com
Clinicians, when trying to apply trial results to patient care, need to individualize patient care
and, potentially, manage patients based on results of subgroup analyses. Apparently …

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …

G Mancia, G De Backer, A Dominiczak… - European heart …, 2007 - academic.oup.com
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

BC Fellström, AG Jardine, RE Schmieder… - … England Journal of …, 2009 - Mass Medical Soc
Background Statins reduce the incidence of cardiovascular events in patients at high
cardiovascular risk. However, a benefit of statins in such patients who are undergoing …